The document provides a technical analysis and recommendation to buy DISHMAN stock. Key points include: - DISHMAN is a leading mid-cap pharma stock currently in strong momentum. - The stock has formed an up move and erased earlier losses, indicating strong strength. - Increasing trading volumes show growing appetite for the stock. - Based on Fibonacci extension levels, the stock has a target price of Rs. 288 in the near term. - Given the positive technical analysis, the recommendation is to buy DISHMAN stock.